Laboratory of Vision and Optics (LVO)-Vardinoyiannion Eye Institute of Crete (VEIC), School of Medicine, University of Crete, Heraklion, Crete, Greece.
Epsom and St Helier University Hospitals NHS Trust, Surrey, United Kingdom.
Cornea. 2023 Jun 1;42(6):680-686. doi: 10.1097/ICO.0000000000003168. Epub 2022 Nov 21.
The aim of this study was to present the 3-year outcomes after simultaneous transepithelial phototherapeutic keratectomy (t-PTK) and conventional photorefractive keratectomy (PRK) followed by corneal crosslinking (CXL) for keratoconus.
In this prospective, interventional case series, patients with progressive keratoconus underwent simultaneous t-PTK and conventional PRK followed by CXL (Cretan protocol plus). Visual, refractive, and topographic outcomes were evaluated along with endothelial cell density (ECD) preoperatively and at 1, 2, and 3 years postoperatively.
Twenty-two patients (31 eyes) were enrolled. No intraoperative or postoperative complications were observed in any of the patients. Logarithm of the minimum angle of resolution (logMAR) mean uncorrected and mean corrected distance visual acuity improved from 0.81 ± 0.40 and 0.18 ± 0.21 preoperatively to 0.38 ± 0.33 ( P < 0.001) and 0.06 ± 0.12 ( P < 0.001) at 3-year follow-up. Mean spherical equivalent improved from -5.39 ± 3.89 diopters (D) preoperatively to -2.29 ± 2.65 D ( P < 0.001) at 3 years postoperatively. Mean corneal astigmatism reduced from -4.70 ± 2.86 D preoperatively to -3.55 ± 2.45 D ( P = 0.001) at 3 years postoperatively. No ECD alterations were observed throughout the 3-year follow-up ( P > 0.05).
Simultaneous t-PTK and conventional PRK followed by CXL seems to be an effective and safe treatment for progressive keratoconus over 3-year follow-up.
本研究旨在介绍同时行经上皮准分子激光角膜切削术(t-PTK)和常规光折射性角膜切削术(PRK)联合角膜交联(CXL)治疗圆锥角膜的 3 年结果。
在这项前瞻性、干预性病例系列研究中,进展性圆锥角膜患者接受了同时行 t-PTK 和常规 PRK 联合 CXL(克里特协议加)治疗。评估了患者的视力、屈光和地形图,以及手术前后内皮细胞密度(ECD)。
共有 22 名患者(31 只眼)入选。所有患者均未观察到术中或术后并发症。未经矫正和经矫正的最佳矫正视力对数最小角分辨率(logMAR)从术前的 0.81±0.40 和 0.18±0.21 提高到术后 3 年的 0.38±0.33(P<0.001)和 0.06±0.12(P<0.001)。平均等效球镜从术前的-5.39±3.89 屈光度(D)改善至术后 3 年的-2.29±2.65 D(P<0.001)。平均角膜散光从术前的-4.70±2.86 D 减少至术后 3 年的-3.55±2.45 D(P=0.001)。在整个 3 年随访过程中,ECD 无明显变化(P>0.05)。
对于进展性圆锥角膜患者,同时行 t-PTK 和常规 PRK 联合 CXL 在 3 年随访中似乎是一种有效且安全的治疗方法。